IHI Innovation Report: Addressing the Opioid Crisis in the United States

Martin L, Raiderman M, Hyatt J, Kruger J. Resolve the opioid crisis in America. IHI Innovation Report Cambridge, Massachusetts State: Medical Improvement Research Institute; April 2016

In the United States, morbidity and mortality rates of opioid abuse, abuse and overdose continue to rise, posing a crisis to patients, families and communities. The IHI Innovation Team conducted a survey to investigate the role of healthcare, community, and individuals in a community-driven integrated multi-sector approach to scan best practices and address the opioid crisis

Efforts to reduce prescription opioid use and abuse in the United States discussed the main reasons that had little effect in suppressing crises so far in the United States.

Emphasize the gap in current efforts and emphasize the need for a coordinated approach throughout the community.

Presentation of a high-level structure for a systematic approach at the community level to cope with the US opioid crisis

Note: In the previous report, the Joint Committee started the "Pain as Fifth Vital Sign" initiative, giving the impression that the Joint Committee is responsible for promoting mainly focus on pain management I misrepresented it as giving to the reader. This revision corrects errors and more accurately captures convergence of factors leading to pain management. [June 2016]

The opioid epidemic is one of the most severe public health crises in the United States and the current crisis of opioid overdose requires an innovative approach. Authorities have taken important steps to reduce public exposure to opioids, to prevent new cases of opioid use disorders (also known as opioid poisoning) and to support the treatment of people with this disorder It was. The FDA continues to commit to responding to this domestic crisis in all aspects, with an emphasis on encouraging innovation of medical products to prevent new cases of opioid abuse and poisoning and to treat addicts It is. As of 31 May 2018, the FDA, as part of an important effort to cope with the spread of opioid abuse and abuse, to promote the development of medical devices including diagnostic tests and digital medical technology (mobile medical applications) Innovation challenge started. To help fight the opioid crisis and to achieve the goal of preventing and treating opioid use disorders

It is clear that the United States is in the midst of a serious opioid epidemic, dealing with this crisis is a priority for the public health industry. In fact, even those who call epidemics the most serious epidemic in the history of the United States 2 It is estimated that in 2009 2 92 million American adults reported using prescription opioids. From 1999 to 2015, the number of deaths from opioids involved in overdose is quadrupled and more than 33,000 people died in 2015. The number increases

Oregon has experienced an overdose of opioids as well as the whole of the United States. To cope with this crisis, the Oregon Health Authority (OHA) conducted a strategic opioid initiative that gathered stakeholders and combines public health and medical system activities across departments. Recent data shows progress: Oregon's prescription opioid overdose mortality rate fell the most between 2015 and 2016. The opioid initiative, launched in 2015, focuses on increasing access to non-opioid pain treatment, support for naloxone's drug adjuvant treatment and opioid use, and improved patient care with reduced opioid prescription and use. And safety and population health. Data for providing information for policy and intervention

Integration of public health and health care strategies to cope with opioid epidemic: Oregon Health Bureau's Opioid Initiative